ÂÜÀòÂÒÂ×

Mélanie Fauvel has a diverse work experience in the field of quality assurance and clinical research. Mélanie has held various roles in different organizations, showcasing their expertise and knowledge in these areas.

Mélanie'smost recent position was as a Senior Director Quality Assurance at TRIO - Translational Research in Oncology since April 2023. Prior to this, they worked as a Clinical QA Unit Manager at the same company from July 2019 to April 2023, and as a QA Clinical Project Manager from February 2017 to July 2019.

Before joining TRIO, Mélanie worked as a Clinical QA Consultant at Sunnikan from January 2014 to February 2017, providing their expertise in quality assurance for clinical trials. Mélanie also gained experience as a Clinical Quality Assurance Associate at Novartis from August 2013 to December 2013.

Additionally, Mélanie held positions at AP-HP, Assistance Publique - Hôpitaux de Paris, where they worked as a Clinical QA officer / Clinical Trial Safety assessor from September 2012 to August 2013, and as a Hospital Pharmacist from November 2005 to November 2009. Mélanie also served as a GLP Quality Assurance Manager at GenoSafe from November 2010 to July 2012 and participated in GMP inspections at ANSM Agence nationale de sécurité du médicament et des produits de santé from November 2009 to October 2010.

Overall, Mélanie Fauvel's extensive work experience in quality assurance and clinical research showcases their expertise and ability to manage projects in these fields.

Mélanie Fauvel has a Diplôme d'Etudes Spécialisées en Pharmacie Hospitalière et des Collectivités and a Diplôme d'Etat de Docteur en Pharmacie from Paris-Sud University (Paris XI), with a field of study in Pharmacie. Mélanie also has a DU "Pharmacoéconomie des médicaments et des dispositifs médicaux" from Université Paris Cité. In addition, they hold a Master 2 "Pharmacotechnie et biopharmacie" from Paris-Sud University (Paris XI), with a field of study in Nanotechnologies. Mélanie also has a DIU du CESAM from Pierre and Marie Curie University, specializing in Statistics applied to medicine.